| Aug 6 |
MaxCyte, Inc. (MXCT) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 6 |
MaxCyte GAAP EPS of -$0.09 beats by $0.04, revenue of $10.4M beats by $2.47M
|
| Aug 6 |
MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance
|
| Jul 17 |
MaxCyte (MXCT) is on the Move, Here's Why the Trend Could be Sustainable
|
| Jul 9 |
MaxCyte to Report Second Quarter 2024 Financial Results on August 6, 2024
|
| Jun 14 |
President of MaxCyte Maher Masoud Buys More Stock
|
| Jun 13 |
Does MaxCyte (MXCT) Have the Potential to Rally 85% as Wall Street Analysts Expect?
|
| Jun 13 |
Recent Price Trend in MaxCyte (MXCT) is Your Friend, Here's Why
|
| Jun 11 |
Insider Buying: President and CEO Maher Masoud Acquires 100,000 Shares of MaxCyte Inc (MXCT)
|
| May 29 |
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
|
